KURA — Kura Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $760.52m
- $106.79m
- $67.48m
Annual cashflow statement for Kura Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -130 | -136 | -153 | -174 | -279 |
| Depreciation | |||||
| Non-Cash Items | 28.6 | 28 | 19.1 | 21.3 | 29.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.22 | -2.98 | 7.82 | 286 | 184 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -105 | -110 | -125 | 134 | -64.1 |
| Capital Expenditures | -1.15 | -0.626 | -0.168 | -0.472 | -6.64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -126 | 33.3 | 15.7 | -101 | -6.46 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -127 | 32.6 | 15.6 | -102 | -13.1 |
| Financing Cash Flow Items | -0.611 | -0.575 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.44 | 38.6 | 94.8 | 154 | 1.79 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -235 | -38.9 | -14.5 | 187 | -75.4 |